Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation

Currently there is neither a vaccine nor an effective treatment strategy available for COVID19. Here, Hurlburt et al. provide the crystal structure of a patient-derived monoclonal antibody neutralizing SARS-CoV-2 via shedding of the S1 subunit and competing for the receptor binding domain.

Dades bibliogràfiques

Autors principals:	Nicholas K. Hurlburt, Emilie Seydoux, Yu-Hsin Wan, Venkata Viswanadh Edara, Andrew B. Stuart, Junli Feng, Mehul S. Suthar, Andrew T. McGuire, Leonidas Stamatatos, Marie Pancera
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2020-10-01
Col·lecció:	Nature Communications
Accés en línia:	https://doi.org/10.1038/s41467-020-19231-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!